Full-Time
Senior Program Manager
Scrum Master
Posted on 8/21/2026
CVS Health
10,001+ employees
Healthcare, insurance, PBM, and retail pharmacy
Compensation Overview
$118.5k - $236.9k/yr
Company Historically Provides H1B Sponsorship
Virginia, USA
Remote
Bachelor's
 Business & Strategy (1) |
|---|
Get referred to CVS Health
See people who can refer or advise you
- At least 8 years of project management experience.
- A bachelor's degree or equivalent experience.
- Lead end-to-end delivery of Aetna Transactional Cache initiatives, including MarkLogic-to-MongoDB migrations, cloud enablement, data platform modernization, and application onboarding.
- Manage integrated program plans, milestones, schedules, dependencies, and critical path activities.
- Coordinate delivery across engineering, architecture, infrastructure, DevOps, security, data, and business teams.
- Drive execution of consumer cutovers, migration waves, platform readiness, and production deployments.
- Facilitate executive governance forums, steering committees, L2/L3 reviews, and leadership updates.
- Prepare executive-ready program status reports, dashboards, presentations, decision papers, and meeting materials.
- Ensure alignment among business sponsors, product owners, architecture teams, and delivery organizations.
- Escalate critical issues and drive timely resolution of risks and blockers.
- Manage multi-million-dollar program budgets, forecasts, funding requests, and resource planning activities.
- Track financial performance, budget variances, vendor spend, and capacity utilization.
- Partner with finance and leadership teams to support annual planning, investment decisions, and business case development.
- Identify opportunities for cost optimization and operational efficiencies.
- Establish and maintain program risk, issue, and dependency management processes.
- Drive mitigation planning and resolution of cross-functional program challenges.
- Ensure visibility of key program risks through leadership reporting and governance reviews.
- Apply Agile, Scrum, and hybrid delivery methodologies across multiple workstreams.
- Implement best practices for program management, reporting, metrics, and governance.
- Track key performance indicators, delivery metrics, and value realization.
- Support roadmap planning and prioritization activities.
- Partner with architects and engineering leaders to understand technical solutions and migration strategies.
- Collaborate on cloud adoption, modernization roadmaps, API strategies, and data platform initiatives.
- Contribute to strategic planning for enterprise data architecture and future-state capabilities.
- Healthcare background.
- Proficiency in Excel and Microsoft Teams.
- Migration experience.
- Proficiency in PowerPoint and Outlook.
- Strong written and verbal communication skills.
- Strong organizational skills.
- Ability to simultaneously manage multiple projects.
- Ability to work independently.
- High degree of attention to detail.
CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.
Company Size
10,001+
Company Stage
IPO
Headquarters
Woonsocket, Rhode Island
Founded
1963
Get referred to CVS Health
See people who can refer or advise you
Simplify's Take
What believers are saying
- CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 on August 5, 2026.
- CVS and Eli Lilly launch Zepbound and Foundayo pricing in-app by early Q4 2026.
- CVS opened pharmacy-focused Houston stores and plans nearly 20 nationwide openings.
What critics are saying
- Reuters said Caremark expects weaker client retention after August 5, 2026 results.
- Louisiana settled three PBM lawsuits with CVS for $45 million on February 20, 2026.
- Tennessee's FAIR Rx Act threatens 137 CVS pharmacies and MinuteClinics, risking forced divestiture.
What makes CVS Health unique
- CVS integrates Aetna, Caremark, and 9,000 pharmacies across U.S. scale.
- August 5, 2026 results showed all three segments beat revenue expectations.
- Teresa Heitsenrether joins the board November 18, 2026, signaling data-driven healthcare execution.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
Company Equity
Wellness Program
Professional Development Budget
Paid Vacation
Paid Holidays
Company News
CVS Health has appointed Teresa Heitsenrether, a senior executive from JPMorgan Chase with extensive data and analytics experience, to its board of directors. The move follows the resignation of board member Larry M. Robbins. The appointment signals CVS Health's focus on technology and data-driven healthcare at the governance level. The company, valued at approximately $120bn, operates an integrated healthcare model spanning insurance, pharmacy benefits, and retail services. Heitsenrether's data expertise aligns with CVS Health's strategy to leverage digital capabilities and operational efficiency across its businesses, including Aetna and Caremark. The company faces challenges including high debt levels and reimbursement pressures in a competitive market alongside UnitedHealth Group and Cigna.
CVS Health reported second quarter revenue of $106.1 billion, beating analyst estimates of $99.41 billion by 6.7%. Adjusted earnings per share came in at $2.58, surpassing expectations of $1.85 by 39.4%. Management attributed strong performance to specialty pharmacy and Medicare Advantage, with CEO David Joyner noting improvements from actions taken in Aetna and Caremark. The company raised its full-year adjusted EPS guidance to $8 at the midpoint. However, analysts raised concerns about sustainability. Management acknowledged ongoing challenges in the 340B program and normalisation of script share gains from Rite Aid. To offset these headwinds, executives pointed to biosimilars and investments in service technology. The company has committed $20 billion over a decade to AI and technology investments, with operational savings already being realised.
Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.
AbbVie has announced a $10.9 billion acquisition of Apogee Therapeutics in June 2026, aiming to strengthen its drug pipeline. The biopharmaceutical company reported FY 2025 revenue of nearly $61.2 billion, up roughly 8.6% year-on-year. Net income reached close to $4.2 billion, reflecting a net margin of approximately 6.9%, down from 7.6% the previous year. Free cash flow for the period was nearly $17.8 billion. CVS Health reported FY 2025 revenue of approximately $402.1 billion, representing growth of nearly 7.8%. The integrated healthcare provider serves around 37 million medical members and manages 1.9 billion prescriptions annually through its Health Services segment. Net income was close to $1.8 billion, yielding a net margin of roughly 0.4%, down from 1.2% in FY 2024.
CVS Health reported second-quarter net income of $2.98 billion, or $2.31 per share, significantly beating analyst expectations of $1.85 per share. Revenue rose 7% to $106.10 billion, surpassing the forecast of $100.11 billion. The company raised its full-year adjusted earnings guidance to between $7.90 and $8.10 per share, up from $7.30 to $7.50 per share. Revenue guidance increased to at least $414 billion from $405 billion. CVS announced a partnership with Eli Lilly, with the CVS Health app to display pricing for Lilly's weight loss drugs Zepbound and Foundayo starting in early fourth quarter 2026. The company also reduced MinuteClinic virtual weight loss consultations to $29, eliminating membership fees.